Nathalie Adda Enanta Pharmaceuticals Inc (ENTA) insider trading activity

Nathalie Adda is Sr. VP & Chief Medical Officer of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 34,982 shares of ENTA, which is worth approximately $315,187. The most recent transaction as insider was on Apr 04, 2022, when has been sold 32,785 shares (Common Stock) at a price of $72.08 per share, resulting in proceeds of $2,363,143. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35K

0% 3M change

0% 12M change

Total Value Held $315,187

Nathalie Adda Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 04 2022	SELL Open market or private sale	$2,363,143 $72.08 p/Share	32,785 Reduced 48.38%	34,982 Common Stock
Apr 04 2022	BUY Exercise of conversion of derivative security	$1,698,591 $51.81 p/Share	32,785 Added 32.61%	67,767 Common Stock
Apr 01 2022	SELL Open market or private sale	$3,591,711 $71.04 p/Share	50,559 Reduced 59.1%	34,982 Common Stock
Apr 01 2022	BUY Exercise of conversion of derivative security	$1,852,987 $36.65 p/Share	50,559 Added 37.15%	85,541 Common Stock
Mar 02 2022	SELL Open market or private sale	$874,544 $70.07 p/Share	12,481 Reduced 26.3%	34,982 Common Stock
Mar 02 2022	BUY Exercise of conversion of derivative security	$542,424 $43.46 p/Share	12,481 Added 20.82%	47,463 Common Stock
Mar 01 2022	SELL Open market or private sale	$1,719,794 $70.66 p/Share	24,339 Reduced 41.03%	34,982 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	$1,057,773 $43.46 p/Share	24,339 Added 29.09%	59,321 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$59,615 $62.49 p/Share	954 Reduced 2.65%	34,982 Common Stock
Feb 14 2022	BUY Grant, award, or other acquisition	-	3,034 Added 7.79%	35,936 Common Stock
Jan 11 2022	SELL Open market or private sale	$879,150 $70.13 p/Share	12,536 Reduced 27.59%	32,902 Common Stock
Jan 11 2022	BUY Exercise of conversion of derivative security	$460,447 $36.73 p/Share	12,536 Added 21.62%	45,438 Common Stock
Dec 01 2021	SELL Payment of exercise price or tax liability	$73,827 $87.68 p/Share	842 Reduced 2.5%	32,902 Common Stock
Dec 01 2021	SELL Open market or private sale	$1,182,586 $87.45 p/Share	13,523 Reduced 29.13%	32,902 Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	$621,923 $45.99 p/Share	13,523 Added 22.56%	46,425 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	-	6,800 Added 16.77%	33,744 Common Stock
Nov 01 2021	SELL Open market or private sale	$813,213 $85.18 p/Share	9,547 Reduced 26.16%	26,944 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$463,220 $48.52 p/Share	9,547 Added 20.74%	36,491 Common Stock
Oct 11 2021	SELL Open market or private sale	$284,666 $70.34 p/Share	4,047 Reduced 13.06%	26,944 Common Stock
Oct 11 2021	BUY Exercise of conversion of derivative security	$175,883 $43.46 p/Share	4,047 Added 11.55%	30,991 Common Stock
Oct 08 2021	SELL Open market or private sale	$942,921 $70.09 p/Share	13,453 Reduced 33.3%	26,944 Common Stock
Oct 08 2021	BUY Exercise of conversion of derivative security	$584,667 $43.46 p/Share	13,453 Added 24.98%	40,397 Common Stock
Dec 15 2020	SELL Payment of exercise price or tax liability	$65,481 $42.52 p/Share	1,540 Reduced 5.41%	26,944 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	-	5,250 Added 15.56%	28,484 Common Stock
Nov 20 2020	BUY Grant, award, or other acquisition	-	7,600 Added 24.65%	23,234 Common Stock

Nathalie Adda

Sr. VP & Chief Medical Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTA shares.

Notify only if

Value

Insider Trading

Get notified when an Enanta Pharmaceuticals Inc insider buys or sells ENTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to ENANTA PHARMACEUTICALS INC

Track Activities on ENTA

Account